Don't miss the new "Science behind the Study" editorial by Jochen Reiser, MD, PhD (President, University of Texas Medical Branch), and Julie Ingelfinger, MD (Deputy Editor, New England Journal of Medicine), published July 31 in the New England Journal of Medicine to accompany the article by Hengel et al. presenting ISGD-supported research on the role of anti-nephrin autoantibodies in minimal change disease and idiopathic nephrotic syndrome. It provides a thorough and accessible explanation of the science, along with excellent illustrations of glomerular physiology and the novel hybrid immunoprecipitation technique used by the research team.
For additional information on this groundbreaking research, explore our exclusive Q&A and podcast episode with the authors.
As Dr. Reiser commented on X:
COMMENTS